Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study
Clinical trial NCT04880746 · UNKNOWN
Trial details
- NCT number
- NCT04880746
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-17
- Primary completion
- 2024-10-17
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.